Suzanne Pourbaix

663 total citations
15 papers, 251 citations indexed

About

Suzanne Pourbaix is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suzanne Pourbaix has authored 15 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pharmacology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suzanne Pourbaix's work include Cardiac Imaging and Diagnostics (2 papers), Epilepsy research and treatment (2 papers) and Coronary Interventions and Diagnostics (2 papers). Suzanne Pourbaix is often cited by papers focused on Cardiac Imaging and Diagnostics (2 papers), Epilepsy research and treatment (2 papers) and Coronary Interventions and Diagnostics (2 papers). Suzanne Pourbaix collaborates with scholars based in Belgium, Switzerland and Netherlands. Suzanne Pourbaix's co-authors include Jean‐Pierre Desager, Marc Carlier, Yves Berger, Luc Missault, C. Harvengt, Jean Boland, Luc Muyldermans, Edouard Benit, Pierre Materne and Francis Heller and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and Biochemical Pharmacology.

In The Last Decade

Suzanne Pourbaix

15 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Pourbaix Belgium	9	104	86	68	38	37	15	251
Laurence Gabriël Belgium	10	172 1.7×	62 0.7×	82 1.2×	17 0.4×	47 1.3×	37	302
Paul Thomas United Kingdom	9	180 1.7×	76 0.9×	63 0.9×	18 0.5×	165 4.5×	12	361
Michael Koenen‐Bergmann United States	7	98 0.9×	354 4.1×	30 0.4×	6 0.2×	36 1.0×	8	558
Terri Schnurr Canada	8	291 2.8×	41 0.5×	72 1.1×	16 0.4×	231 6.2×	10	443
Farbod Raiszadeh United States	12	148 1.4×	31 0.4×	71 1.0×	11 0.3×	6 0.2×	37	479
James P. Whipple United States	6	190 1.8×	35 0.4×	284 4.2×	9 0.2×	171 4.6×	9	469
Rubina Sunderji Canada	10	201 1.9×	37 0.4×	61 0.9×	7 0.2×	91 2.5×	21	323
A DREISBACH United States	6	94 0.9×	36 0.4×	55 0.8×	3 0.1×	7 0.2×	6	335
Ines Potočnjak Croatia	11	133 1.3×	38 0.4×	60 0.9×	4 0.1×	7 0.2×	34	390
Narith N. Ou United States	11	175 1.7×	12 0.1×	34 0.5×	14 0.4×	73 2.0×	23	465

Countries citing papers authored by Suzanne Pourbaix

Since Specialization

Citations

This map shows the geographic impact of Suzanne Pourbaix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Pourbaix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Pourbaix more than expected).

Fields of papers citing papers by Suzanne Pourbaix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Pourbaix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Pourbaix. The network helps show where Suzanne Pourbaix may publish in the future.

Co-authorship network of co-authors of Suzanne Pourbaix

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Pourbaix. A scholar is included among the top collaborators of Suzanne Pourbaix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Pourbaix. Suzanne Pourbaix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Landi, Antonio, Dik Heg, Pim A.L. Tonino, et al.. (2024). Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial. European Journal of Internal Medicine. 126. 89–94. 4 indexed citations

Landi, Antonio, Dik Heg, Helen Routledge, et al.. (2024). Negative selection bias for women inclusion in a clinical trial. International Journal of Cardiology. 408. 132138–132138. 2 indexed citations

Claeys, Marc J., Jean‐François Argacha, Philippe Collart, et al.. (2020). Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study. Acta cardiologica. Supplementum. 76(8). 863–869. 23 indexed citations

Gevaert, Sofie, Patrick Coussement, Christophe Beauloye, et al.. (2019). Vulnerability to cardiac arrest in patients with ST elevation myocardial infarction: Is it time or patient dependent? Results from a nationwide observational study. European Heart Journal Acute Cardiovascular Care. 9(4_suppl). S153–S160. 3 indexed citations

Claeys, Marc J., et al.. (2016). Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 3(4). pvw043–pvw043. 13 indexed citations

Benit, Edouard, Luc Missault, Marc Carlier, et al.. (1997). Brachial, radial, or femoral approach for elective Palmaz-Schatz stent implantation: A randomized comparison. Catheterization and Cardiovascular Diagnosis. 41(2). 124–130. 80 indexed citations

Mary-Rabine, L, et al.. (1994). [Coronary-subclavian steal syndrome: an unusual cause of recurrent myocardial ischemia following aortocoronary bypass].. PubMed. 49(6). 342–5. 1 indexed citations

Pourbaix, Suzanne, et al.. (1993). Immediate and long-term results of percutaneous coronary angioplasty in patients aged 70 years or older. European Heart Journal. 14(3). 398–402. 7 indexed citations

Installé, Etienne, et al.. (1987). Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure. The American Journal of Cardiology. 60(5). 46–52. 15 indexed citations

10.

Pourbaix, Suzanne, et al.. (1985). Absolute bioavailability of mianserin tablets and solution in healthy humans. European Journal of Drug Metabolism and Pharmacokinetics. 10(4). 315–323. 11 indexed citations

11.

Pourbaix, Suzanne, et al.. (1985). Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.. PubMed. 23(8). 447–51. 25 indexed citations

12.

Pourbaix, Suzanne, et al.. (1985). Absolute bioavailability of amiodarone in normal subjects. Clinical Pharmacology & Therapeutics. 37(2). 118–123. 41 indexed citations

13.

Desager, Jean‐Pierre, Suzanne Pourbaix, Étienne Dumont, & C. Harvengt. (1984). Metabolic Interaction of Cimetidine With Alprazolam and Triazolam After Repeated Doses. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 270(1). 170–170. 1 indexed citations

14.

Pourbaix, Suzanne, et al.. (1984). Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters. Biochemical Pharmacology. 33(22). 3661–3666. 16 indexed citations

15.

Heller, F. & Suzanne Pourbaix. (1982). [Peroxisomes and hypolipidemic agents ].. PubMed. 58(28-29). 1712–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact